StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
422
Publishing Date
2024 - 01 - 16
525
2024 - 01 - 08
552
2023 - 11 - 14
547
2023 - 11 - 13
534
2023 - 11 - 09
677
2023 - 11 - 08
665
2023 - 11 - 07
754
2023 - 11 - 06
603
2023 - 11 - 02
769
2023 - 11 - 01
712
2023 - 10 - 30
531
2023 - 10 - 26
595
2023 - 10 - 24
537
2023 - 10 - 16
529
2023 - 09 - 07
555
2023 - 09 - 06
611
2023 - 09 - 05
574
2023 - 08 - 14
549
2023 - 08 - 10
565
2023 - 08 - 09
554
2023 - 08 - 08
588
2023 - 08 - 03
654
2023 - 08 - 02
603
2023 - 08 - 01
538
2023 - 07 - 27
602
2023 - 07 - 26
526
2023 - 05 - 16
529
2023 - 05 - 15
617
2023 - 05 - 11
691
2023 - 05 - 10
649
2023 - 05 - 09
730
2023 - 05 - 08
596
2023 - 05 - 04
775
2023 - 05 - 03
700
2023 - 05 - 02
644
2023 - 05 - 01
540
2023 - 04 - 27
533
2023 - 04 - 24
535
2023 - 04 - 19
534
2023 - 03 - 14
549
2023 - 03 - 02
528
2023 - 03 - 01
573
2023 - 02 - 28
606
2023 - 02 - 27
524
2023 - 02 - 23
596
2023 - 02 - 22
552
2023 - 02 - 09
597
2023 - 02 - 08
524
2022 - 11 - 14
545
2022 - 11 - 03
565
2022 - 03 - 01
610
2022 - 02 - 24
538
2022 - 02 - 22
523
2021 - 11 - 15
549
2021 - 11 - 10
561
2021 - 11 - 09
525
2021 - 11 - 04
558
2021 - 11 - 03
534
2021 - 11 - 01
524
2021 - 08 - 05
561
Sector
Commercial services
12
Communications
9
Consumer durables
12
Consumer non-durables
13
Consumer services
15
Distribution services
4
Electronic technology
43
Energy minerals
8
Finance
45
Health care and social assistance
1
Health services
1
Health technology
103
Industrial services
7
Information
4
Manufacturing
30
Mining, quarrying, and oil and gas extraction
2
N/a
1
Non-energy minerals
10
Process industries
22
Producer manufacturing
36
Professional, scientific, and technical services
3
Real estate and rental and leasing
2
Retail trade
7
Technology services
46
Transportation
5
Utilities
10
Tags
5g
3
Acquisition
5
Application
6
Awards
3
Battery
3
Biopharma
5
Biotech-beach
4
Cancer
5
Ceo
4
Clinical-trials-phase-ii
3
Clinical-trials-phase-iii
3
Collaboration
4
Commercialization
3
Conference
27
Covid
8
Covid-19
6
Designation
7
Device
5
Disease
3
Drug
9
Electronics
3
Energy
11
Enroll
4
Europe
6
Events
12
Fda
7
Fda-approvals
3
Financial results
7
Genetown
3
Growing
4
Growth
25
Huntington
3
Life science
11
Liver
5
Market
5
Media
5
Money
4
N/a
358
Offering
19
Ongoing
4
Patent
5
People
8
Pharma
6
Pharmaceutical
4
Phase 1
6
Phase 2
7
Phase 3
9
Positive
4
Potential
4
Presentation
6
Renewable
5
Research
19
Results
20
Technology
7
Test
8
Therapeutics
6
Therapy
8
Treatment
6
Trial
11
Vaccine
4
Entities
3m company
2
Abb ltd
4
Abbott laboratories
4
Abbvie inc.
2
Achieve life sciences, inc.
2
Alstom
2
American airlines group, inc.
2
Appian corporation
2
Apple inc.
2
Applied materials, inc.
2
Aptorum group limited
2
Arrival
10
Atai life sciences n.v.
2
Axalta coating systems ltd.
2
Becton, dickinson and company
2
Boston scientific corporation
2
Cadiz, inc.
2
Canaan inc.
3
Cenovus energy inc
2
Cnh industrial n.v.
2
Cnx resources corporation
3
Coherus biosciences, inc.
2
Crinetics pharmaceuticals, inc.
3
Diageo plc
2
Dice therapeutics, inc.
2
Dow inc.
6
Eli lilly and company
2
Enbridge inc
2
Ericsson
3
Extreme networks, inc.
2
Flex ltd.
2
Flowserve corporation
2
Ford motor company
2
Gannett co., inc.
5
General electric company
5
Glaukos corporation
2
Glaxosmithkline plc
2
Global industrial co
2
Hubspot, inc.
5
Infosys limited
2
Innoviva, inc.
2
Intel corporation
3
Jabil inc.
2
Johnson & johnson
8
Johnson controls international plc
4
Katapult holdings inc
2
Kellogg company
3
Mannkind corporation
2
Microsoft corporation
2
Mondelez international, inc.
2
Morgan stanley
8
National grid transco, plc
2
Nektar therapeutics
2
Nikola corporation
2
Orange
4
Rockwell automation, inc.
3
Sanofi
6
Sap se
3
Takeda pharmaceutical company limited
3
Trimble inc.
3
Symbols
AAL
2
AAPL
2
ABB
4
ABBV
2
ABT
4
ACHV
2
ALSMY
2
AMAT
2
AOMFF
2
APM
2
APPN
2
ARVL
10
ATAI
2
AXTA
2
BDX
2
BSX
2
CAN
3
CDZI
2
CHRS
2
CNHI
2
CNX
3
CRNX
3
CVE
2
DEO
2
DICE
2
DOW
6
ENB
2
ERIC
3
EXTR
2
F
2
FLEX
2
FLOW
2
FLS
2
FNCTF
4
GCI
5
GE
5
GIC
2
GKOS
2
GSK
2
HUBS
5
INFY
2
INTC
3
INVA
2
JBL
2
JCI
4
JNJ
8
K
3
KPLT
2
LLY
2
MDLZ
2
MMM
2
MNKD
2
MS
8
MSFT
2
NGG
2
ROK
3
SAP
3
SNY
6
TAK
3
TRMB
3
Exchanges
Amex
7
Nasdaq
262
Nyse
191
Crawled Date
2021 - 10 - 25
1
2021 - 09 - 19
1
2021 - 09 - 18
1
2021 - 09 - 16
7
2021 - 09 - 15
412
Crawled Time
00:00
6
00:20
1
01:00
4
02:00
1
03:00
6
04:00
2
05:00
3
06:00
4
07:00
5
08:00
3
09:00
1
10:00
12
11:00
24
12:00
34
12:15
43
13:00
40
13:15
26
14:00
26
14:15
13
14:59
1
15:00
19
15:15
10
16:00
12
16:20
1
17:00
23
18:00
17
19:00
8
20:00
10
21:00
32
22:00
23
23:00
12
Source
cytosorbents.com
1
feed.businesswire.com
5
hightideinc.com
1
ir.cyren.com
1
ir.sypris.com
1
jaguarhealth.gcs-web.com
1
velodynelidar.com
1
www.4dpharmaplc.com
1
www.achievelifesciences.com
1
www.aemetis.com
1
www.allegiancebank.com
1
www.amcnetworks.com
1
www.ampiopharma.com
1
www.biospace.com
64
www.blackknightinc.com
1
www.broadstone.com
1
www.cadizinc.com
1
www.canaan-creative.com
2
www.canopygrowth.com
1
www.charah.com
1
www.confluent.io
1
www.crinetics.com
2
www.cumulusmedia.com
1
www.cyberoptics.com
1
www.duckcreek.com
1
www.extremenetworks.com
2
www.gannett.com
5
www.globenewswire.com
103
www.hubspot.com
5
www.karauctionservices.com
1
www.levistrauss.com
1
www.livenationentertainment.com
1
www.nexstar.tv
1
www.nwpipe.com
1
www.ooma.com
1
www.pagerduty.com
1
www.phunware.com
1
www.prnewswire.com
199
www.snowflake.com
1
www.steelcase.com
1
www.thermogenesis.com
1
www.thewaltdisneycompany.com
1
www.wexinc.com
1
www.zynga.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
publishing date :
2021 - 09 - 15
save search
Cyren Announces $10.2 Million Private Placement Priced at a Premium to Market
Published:
2021-09-15
(Crawled : 14:59)
- ir.cyren.com
CYRN
|
News
|
$0.2182
-20.66%
-6.51%
1.1M
|
Technology Services
|
-61.29%
|
O:
-9.0%
H:
5.97%
C:
-7.4%
Orphan Drug Designation Application Submitted by Jaguar Health Subsidiary for Crofelemer for Short Bowel Syndrome with Intestinal Failure Accepted for Review by European Medicines Agency
Published:
2021-09-15
(Crawled : 00:20)
- jaguarhealth.gcs-web.com
JAGX
|
$0.1659
-6.32%
14M
|
Health Technology
|
-92.34%
|
O:
2.13%
H:
2.5%
C:
-1.25%
orphan drug
europe
test
drug
syndros
crofelemer
designation
Sypris Wins Award for Electronic Warfare & Countermeasure Program
Published:
2021-09-15
(Crawled : 16:20)
- ir.sypris.com
SYPR
4
|
$1.61
270
|
Producer Manufacturing
|
-52.27%
|
O:
-0.57%
H:
3.14%
C:
3.14%
program
awards
CytoSorbents to Host International Webinar on the Worldwide Experience Using CytoSorb® in Critically Ill Patients with COVID-19
Published:
2021-09-15
(Crawled : 02:00)
- cytosorbents.com
CTSO
|
$0.812
1.37%
19K
|
Health Technology
|
-90.38%
|
O:
0.24%
H:
0.65%
C:
-1.68%
covid
PagerDuty and Teleport: System access and role escalation when you need it by Mandi Walls
Published:
2021-09-15
(Crawled : 00:00)
- pagerduty.com
PD
|
News
|
$20.7
-0.62%
270K
|
Technology Services
|
-52.87%
|
O:
-0.18%
H:
1.83%
C:
-0.13%
Gloves Market 2021-2025 | Increase In Rubber Production to Boost Growth | 17,000+ Technavio Reports
Published:
2021-09-15
(Crawled : 00:00)
- prnewswire.com
HON
|
News
M
|
$193.37
1.2%
1.3M
|
Producer Manufacturing
|
-14.03%
|
O:
-0.19%
H:
0.06%
C:
-0.73%
growth
Kessler Topaz Meltzer & Check, LLP: Securities Fraud Class Action Filed Against Annovis Bio, Inc.
Published:
2021-09-15
(Crawled : 00:00)
- prnewswire.com
ANVS
|
$10.06
2.13%
70K
|
Health Technology
|
-69.47%
|
O:
0.31%
H:
1.71%
C:
-3.46%
Battery Market 2021-2025 | Rising Inclusion of Renewables in the Energy Mix to Boost Growth | Technavio
Published:
2021-09-15
(Crawled : 00:00)
- prnewswire.com
JCI
|
News
|
$64.175
0.64%
2.7M
|
Producer Manufacturing
|
-15.6%
|
O:
0.0%
H:
0.53%
C:
-0.61%
APTV
|
$69.28
-0.06%
680K
|
Producer Manufacturing
|
-53.37%
|
O:
-0.95%
H:
0.33%
C:
-2.37%
battery
renewable
energy
growth
Cenovus announces Expiration and Results of Any and All Tender Offer
Published:
2021-09-15
(Crawled : 00:00)
- globenewswire.com
CVE
|
$20.985
1.57%
2.3M
|
Energy Minerals
|
126.95%
|
O:
-0.66%
H:
0.33%
C:
-1.77%
results
Callaway Golf Company Announces Pricing of Upsized Public Offering of Common Stock by Selling Stockholder
Published:
2021-09-15
(Crawled : 00:00)
- prnewswire.com
ELY
4
|
$21.33
-1.41%
|
Consumer Durables
|
-29.11%
|
O:
1.33%
H:
3.9%
C:
1.71%
offering
Profile of Entasis Therapeutics ETX0462 Candidate Published in the Journal NaturePublication Details the Discovery and Preclinical Profile of ETX0462, a First-in-Class Candidate Against Multidrug-Resistant Pathogens
Published:
2021-09-15
(Crawled : 23:00)
- biospace.com/
ETTX
|
$2.19
-0.46%
0.46%
|
Health Technology
|
-22.98%
|
O:
-0.7%
H:
2.12%
C:
-3.18%
drug
pathogens
preclinical
pre-clinical
How to Write a Creative Brief in 11 Simple Steps [Examples + Template]
Published:
2021-09-15
(Crawled : 23:00)
- hubspot.com
HUBS
M
|
$643.5
-0.94%
290K
|
Technology Services
|
-5.71%
|
O:
0.0%
H:
1.39%
C:
1.12%
The Best Integrated Marketing Campaigns, According to HubSpot Marketers
Published:
2021-09-15
(Crawled : 23:00)
- hubspot.com
HUBS
M
|
$643.5
-0.94%
290K
|
Technology Services
|
-5.71%
|
O:
0.0%
H:
1.39%
C:
1.12%
market
Aurinia Pharmaceuticals to Present at Upcoming September Investor Conferences
Published:
2021-09-15
(Crawled : 23:00)
- biospace.com/
AUPH
|
$4.915
2.18%
560K
|
Health Technology
|
-77.63%
|
O:
-1.53%
H:
1.09%
C:
-1.79%
conference
presentation
National Retail Properties, Inc. Prices Offering Of $450,000,000 Of 3.000% Senior Unsecured Notes Due 2052
Published:
2021-09-15
(Crawled : 23:00)
- prnewswire.com
USB
|
$39.98
1.37%
3.7M
|
Finance
|
-31.63%
|
O:
0.35%
H:
0.59%
C:
-1.55%
NNN
|
$40.235
1.17%
140K
|
Finance
|
-12.74%
|
O:
-0.35%
H:
1.28%
C:
-0.04%
MS
|
News
0 d
|
$91.305
1.16%
1.7M
|
Finance
|
-12.0%
|
O:
0.46%
H:
0.64%
C:
-1.0%
offering
FDA Approves Tissue-Based NGS Companion Diagnostic for Takeda's Targeted Therapy for NSCLC Patients with EGFR Exon20 Insertion Mutations
Published:
2021-09-15
(Crawled : 23:00)
- prnewswire.com
TMO
|
News
|
$543.03
0.28%
300K
|
Health Technology
|
-5.32%
|
O:
-0.15%
H:
0.12%
C:
-0.3%
TAK
|
News
|
$13.185
0.19%
430K
|
Health Technology
|
-22.65%
|
O:
0.41%
H:
1.11%
C:
0.76%
fda
therapy
fda approval
diagnostic
AngioDynamics to Report Fiscal 2022 First Quarter Financial Results on September 30, 2021
Published:
2021-09-15
(Crawled : 23:00)
- biospace.com/
ANGO
|
$6.155
0.57%
160K
|
Health Technology
|
-76.15%
|
O:
-0.37%
H:
1.08%
C:
-0.04%
financial results
results
Skyharbour Resources Receives $585,000 from Warrant and Option Exercises
Published:
2021-09-15
(Crawled : 23:00)
- globenewswire.com
SYHBF
|
$0.3271
27K
|
Non-Energy Minerals
|
Email alert
Add to watchlist
CareTrust REIT Announces Quarterly Dividend of $0.265 per Share
Published:
2021-09-15
(Crawled : 23:00)
- globenewswire.com
CTRE
|
$23.75
0.04%
130K
|
Finance
|
8.76%
|
O:
0.09%
H:
2.13%
C:
0.6%
BioXcel Therapeutics Presents Results from Ongoing Phase 2 Trial of BXCL701 in Combination with KEYTRUDA® in Aggressive Forms of Prostate Cancer at ESMO
Published:
2021-09-15
(Crawled : 23:00)
- globenewswire.com
BTAI
|
$2.66
4.31%
240K
|
Health Technology
|
-91.43%
|
O:
-0.4%
H:
3.68%
C:
3.34%
phase 2
ongoing
prostate cancer
results
cancer
trial
keytruda
← Previous
1
2
3
4
5
6
7
8
9
…
21
22
Next →
Gainers vs Losers
78%
22%
Top 10 Gainers
AGBA
|
News
|
$1.22
205.0%
86M
|
Finance
NVFY
|
$3.45
63.51%
20M
|
Consumer Durables
EGOX
|
$0.054
50.0%
290M
|
CHRO
|
$1.66
35.51%
70K
|
n/a
INDO
|
$5.43
33.09%
10M
|
Energy Minerals
ZCMD
|
$1.86
28.28%
29M
|
Commercial Services
PAPL
|
$2.07
26.22%
550K
|
RWOD
|
$10.08
26.05%
5.6M
|
n/a
HUSA
4
|
$2.07
23.95%
2.1M
|
Energy Minerals
TPET
|
$0.4001
22.02%
35M
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.